# Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

> **NCT00858923** · PHASE1 · UNKNOWN · sponsor: **Energex Systems, Inc.** · enrollment: 10 (actual)

## Conditions studied

- HIV
- HIV Infections

## Interventions

- **DEVICE:** Energex HemoModulator

## Key facts

- **NCT ID:** NCT00858923
- **Lead sponsor:** Energex Systems, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2009-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858923, "Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00858923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*